TBE-antibody titer study: Is a booster already necessary after 5 years? by Katharina Mahlfleisch, Susanne Pauschenwein, Thomas Pekar

Get full text

Prevalence of asymptomatic SARS-CoV-2 infection in an Austrian cohort by Elisabeth Mara, Verena Breitsching, Tanja Schuster, Thomas Pekar

Get full text

Influenza A and influenza B antibody determination in an Austrian cohort by Elisabeth Mara, Johannes Gratzer, Tobias Mader, Thomas Pekar

Get full text

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria by Elisabeth Mara, Tobias Mader, Johannes Gratzer, Stefanie Hochegger, Thomas Pekar

Get full text

Maternal neurofascin-specific autoantibodies bind to structures of the fetal nervous system during pregnancy, but have no long term effect on development in the rat. by Sonja Hochmeister, Thomas Pekar, Maren Lindner, Maja Kitic, Michaela Haindl, Maria Storch, Franz Fazekas, Christopher Linington

Get full text

Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke. by Sonja Hochmeister, Odilo Engel, Milena Z Adzemovic, Thomas Pekar, Paul Kendlbacher, Manuel Zeitelhofer, Michaela Haindl, Andreas Meisel, Franz Fazekas, Thomas Seifert-Held

Get full text

Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model by Thomas Wanek, Viktoria Zoufal, Mirjam Brackhan, Markus Krohn, Severin Mairinger, Thomas Filip, Michael Sauberer, Johann Stanek, Thomas Pekar, Jens Pahnke, Oliver Langer

Get full text

Plasma midregional pro-adrenomedullin improves prediction of functional outcome in ischemic stroke. by Thomas Seifert-Held, Thomas Pekar, Thomas Gattringer, Nicole E Simmet, Hubert Scharnagl, Christoph Bocksrucker, Christian Lampl, Maria K Storch, Tatjana Stojakovic, Franz Fazekas

Get full text